# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1648234 | Binding | Displacement of [125I]glucagon from human GCGR expressed in CHO cells | Homo sapiens | 41 | ALA1641377 | cell-based format | Scientific Literature | |
2. | ALA1648235 | Functional | Antagonist activity at human GCGR expressed in CHO cells assessed as inhibition of glucagon-induced cAMP accumulation | Homo sapiens | 41 | ALA1641377 | cell-based format | Scientific Literature | |
3. | ALA1648236 | Functional | Antagonist activity at human GIPR expressed in CHO cells assessed as inhibition of glucagon-induced cAMP accumulation | Homo sapiens | 19 | ALA1641377 | cell-based format | Scientific Literature | |
4. | ALA1648240 | Functional | Antidiabetic activity in transgenic mouse expressing human GCGR assessed as inhibition of glucagon-induced blood glucose excursion at 30 mg/kg, po administered 3 hrs before glucagon challenge measured after 48 mins | Mus musculus | 1 | ALA1641377 | organism-based format | Scientific Literature | |
5. | ALA1648241 | Functional | Antidiabetic activity in transgenic mouse expressing human GCGR assessed as inhibition of glucagon-induced blood glucose excursion at 30 mg/kg, po administered 60 mins before glucagon challenge measured after 48 mins | Mus musculus | 4 | ALA1641377 | organism-based format | Scientific Literature | |
6. | ALA1648242 | Functional | Antidiabetic activity in transgenic mouse expressing human GCGR assessed as inhibition of glucagon-induced blood glucose excursion at 10 mg/kg, po administered 60 mins before glucagon challenge measured after 48 mins | Mus musculus | 5 | ALA1641377 | organism-based format | Scientific Literature | |
7. | ALA1648243 | ADME | Drug level in blood of transgenic mouse expressing human GCGR at 10 mg/kg, po after 45 mins | Mus musculus | 1 | ALA1641377 | organism-based format | Scientific Literature | |
8. | ALA1648244 | ADME | Drug level in blood of transgenic mouse expressing human GCGR at 10 mg/kg, po after 120 mins | Mus musculus | 1 | ALA1641377 | organism-based format | Scientific Literature | |
9. | ALA1648245 | ADME | Drug level in blood of transgenic mouse expressing human GCGR at 30 mg/kg, po after 45 mins | Mus musculus | 1 | ALA1641377 | organism-based format | Scientific Literature | |
10. | ALA1648246 | ADME | Drug level in blood of transgenic mouse expressing human GCGR at 30 mg/kg, po after 120 mins | Mus musculus | 1 | ALA1641377 | organism-based format | Scientific Literature | |
11. | ALA1648248 | Functional | Antagonist activity at human GLP1R expressed in CHO cells assessed as inhibition of glucagon-induced cAMP accumulation | Homo sapiens | 1 | ALA1641377 | cell-based format | Scientific Literature | |
12. | ALA1648771 | Functional | Antagonist activity at human PACAPR1 expressed in CHO cells assessed as inhibition of glucagon-induced cAMP accumulation | Homo sapiens | 1 | ALA1641377 | cell-based format | Scientific Literature | |
13. | ALA1648772 | Binding | Inhibition of human ERG | Homo sapiens | 1 | ALA1641377 | single protein format | Scientific Literature | |
14. | ALA1648773 | Binding | Binding affinity to human sodium channel up to 10 uM | Homo sapiens | 1 | ALA1641377 | assay format | Scientific Literature | |
15. | ALA1648774 | Binding | Binding affinity to DLZ-sensitive rabbit calcium channel up to 10 uM | Oryctolagus cuniculus | 1 | ALA1641377 | assay format | Scientific Literature | |
16. | ALA1648775 | Toxicity | Cardiotoxicity in dog assessed as effect on cardiovascular parameters at 1 to 10 mg/kg, iv after 30 mins | Canis lupus familiaris | 1 | ALA1641377 | organism-based format | Scientific Literature | |
17. | ALA1648776 | ADME | Plasma concentration in dog at 1 to 10 mg/kg, iv after 30 mins | Canis lupus familiaris | 1 | ALA1641377 | organism-based format | Scientific Literature | |
18. | ALA1648777 | ADME | Inhibition of CYP2D6 | 1 | ALA1641377 | single protein format | Scientific Literature | ||
19. | ALA1648778 | ADME | Inhibition of CYP3A4 | 1 | ALA1641377 | single protein format | Scientific Literature | ||
20. | ALA1648779 | ADME | Inhibition of CYP2C8 | 1 | ALA1641377 | single protein format | Scientific Literature |